文献速递头颈部肿瘤放疗

原发头颈癌放化疗前是否行颈部淋巴结清扫:肿瘤控制与晚期毒性比较

Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.
PubMed 文献 · Radiother Oncol · 2017-07-26

两组局部、区域、远处控制率及无病生存均无显著差异,但前期颈清扫组≥2级纤维化显著更高。

要点

  • 前期颈清扫未显著改善局部、区域或远处控制及无病生存。
  • 前期颈清扫组≥2级纤维化在所有时间点显著更高(p=0.01)。
  • 水肿和萎缩在两组间无显著差异。

核心结论

  • 前期颈部淋巴结清扫后放化疗与单纯放化疗相比,局部、区域、远处控制及无病生存无显著差异。
  • 前期颈清扫后放化疗的≥2级纤维化显著更突出。

研究设计与样本

  • 中心1的150例接受根治性放化疗,中心2的114例接受前期颈清扫后放化疗。

主要发现

  • 前期颈清扫组与无颈清扫组2年局部控制分别为91.07%和85.96%(p=0.09),区域控制分别为89.22%和83.27%(p=0.12),远处控制分别为76.74%和75.13%(p=0.92)。
  • 两组水肿和萎缩在6、12、18、24个月无显著差异。
  • 前期颈清扫组所有时间点≥2级纤维化比例显著更高(p=0.01)。

临床怎么用

  • 对于N2-N3期头颈鳞癌接受根治性放化疗者,前期颈清扫未显示肿瘤控制获益且增加≥2级纤维化风险。

局限性

  • 回顾性研究,两组治疗来自不同中心,可能存在选择偏倚。
  • 随访时间较长但样本量有限,部分比较未达统计学显著性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE/OBJECTIVE: The benefit of upfront neck dissection (ND) in locally advanced head and neck squamous cell carcinoma (HNSCC) treated with primary (chemo-) radiotherapy (R(C)T) is debated. Therefore, we retrospectively compared disease control and toxicity between patients who were treated with and without upfront ND followed by R(C)T. MATERIAL/METHODS: Two-hundred sixty-four consecutive patients with HNSCC without distant metastases at diagnosis and with lymph node stage N2-N3 were included in 2 centers. Patients were all treated between January 2002 and December 2012, and received definitive R(C)T in center 1 and upfront ND followed by R(C)T in center 2. Clinical data and outcome were assessed retrospectively. Toxicity was scored using the LENT-SOMA scale at 6, 12, 18 and 24months following the end of treatment. RESULTS: We included 150 patients in the group without ND (center 1) and 114 patients in the group with upfront ND (center 2). Mean follow up was 5.68years in the group without ND and 5.83years in the group with upfront ND. Local, regional and distant control after 2years were 91.07% and 85.96% (p=0.09), 89.22% and 83.27% (p=0.12) and 76.74% and 75.13% (p=0.92) in the group with and without upfront ND, respectively. We did not find a significant difference between both groups regarding edema and atrophy at 6, 12, 18 and 24months. We found a trend at all time-points toward worse outcome in the ND group at all time-points (p=0.06). A significantly higher proportion of moderate to severe fibrosis (grade ≥2) was present in the ND group (p=0.01) at all time points. CONCLUSION: There was no significant difference in local, regional or distant control and disease-free survival between both patient populations. Fibrosis, specifically fibrosis grade ≥2 is more prominent following upfront ND and R(C)T when compared to R(C)T alone.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Nevens D, Duprez F, Bonte K, et al. Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity. Radiother Oncol. 2017. PMID: 28756006. doi:10.1016/j.radonc.2017.07.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。